DMAAR

Drugs Made In America Acquisition Corp. - Rights

NASDAQ · us_market

Last price

—

Profile

Quote type: EQUITY
Price rows: 0

Last error: no price data for DMAAR

AI insight · the why

No AI insight generated yet for this ticker.

No Setup Score available for this ticker yet.

🔍

Company & Price

Price (last 5Y) · orange dots are splits

30d return

—

Historical lean-in setups

since 2020 (DD ≥15%, bounce ≥15%)

30d ATM IV

—

implied volatility

1Y alpha vs sector

—

sector benchmark unavailable

30d realized vol

—%

Drawdown from ATH

—

🏦

Institutions & Smart Money

📂

Deep Dive

Fundamentals

as of 2026-05-31

Valuation

Market Cap—

Enterprise Value—

Trailing P/E—

Forward P/E—

PEG Ratio—

P/B-0.52

P/S—

EV / Revenue—

EV / EBITDA—

Profitability

Gross Margin0.00%

Operating Margin0.00%

Profit Margin0.00%

ROE—

ROA-1.46%

Revenue Growth (YoY)—

Earnings Growth (YoY)—

Cash & Leverage

Total Cash$6.14K

Total Debt$0.00

Debt / Equity—

Current Ratio0.03

Free Cash Flow$-1.52M

Operating Cash Flow$-539.19K

Shareholders

Dividend Yield—

Payout Ratio—

% Held by Insiders—

% Held by Institutions—

Shares Outstanding20.40M

Float27.31M